Systemic VHL gene functions and the VHL disease

FEBS Letters

Volumn 586, Issue 11, 2012, Pages 1562-1569

  Bader, Hannah L ^a   Hsu, Tien ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Erythropoietin; Haploid insufficiency; Hemangioblastoma; Hematopoiesis; Inflammation

Indexed keywords

ANGIOPOIETIN RECEPTOR; CHEMOKINE RECEPTOR CXCR4; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; STROMAL CELL DERIVED FACTOR 1; UBIQUITIN PROTEIN LIGASE E3; VASCULOTROPIN RECEPTOR 2; VON HIPPEL LINDAU PROTEIN;

ADAPTIVE IMMUNITY; ANGIOGENESIS; BONE MARROW CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EXTRAMEDULLARY HEMATOPOIESIS; GENE DELETION; GENE FUNCTION; GENE MUTATION; GLUCOSE METABOLISM; HAPLOIDY; HEMANGIOBLASTOMA; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HETEROZYGOSITY; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; INSULIN RELEASE; LOSS OF FUNCTION MUTATION; LYMPHOCYTE; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; POLYCYTHEMIA; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR SUPPRESSOR GENE; UPREGULATION; VHL GENE; VON HIPPEL LINDAU DISEASE;

ANIMALS; HEMATOPOIESIS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; POLYCYTHEMIA; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84861644790     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.04.032     Document Type: Review

References (138)

1. J.G. Herman, F. Latif, Y. Weng, M.I. Lerman, B. Zbar, S. Liu, D. Samid, D.S. Duan, J.R. Gnarra, and W.M. Linehan Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma Proc. Natl. Acad. Sci. U S A 91 1994 9700 9704
2. W.Y. Kim, and W.G. Kaelin Role of VHL gene mutation in human cancer J. Clin. Oncol. 22 2004 4991 5004
3. R.E. Banks, P. Tirukonda, C. Taylor, N. Hornigold, D. Astuti, D. Cohen, E.R. Maher, A.J. Stanley, P. Harnden, A. Joyce, M. Knowles, and P.J. Selby Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer Cancer Res. 66 2006 2000 2011
4. A. Pause, S. Lee, R.A. Worrell, D.Y. Chen, W.H. Burgess, W.M. Linehan, and R.D. Klausner The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins Proc. Natl. Acad. Sci. U S A 94 1997 2156 2161
5. K.M. Lonergan, O. Iliopoulos, M. Ohh, T. Kamura, R.C. Conaway, J.W. Conaway, and W.G. Kaelin Jr. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2 Mol. Cell Biol. 18 1998 732 741
6. T. Kamura, D.M. Koepp, M.N. Conrad, D. Skowyra, R.J. Moreland, O. Iliopoulos, W.S. Lane, W.G. Kaelin Jr., S.J. Elledge, R.C. Conaway, J.W. Harper, and J.W. Conaway Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase Science 284 1999 657 661
7. J. Lisztwan, G. Imbert, C. Wirbelauer, M. Gstaiger, and W. Krek The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity Genes Dev. 13 1999 1822 1833
8. C.E. Stebbins, W.G. Kaelin Jr., and N.P. Pavletich Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function Science 284 1999 455 461
9. W.G. Kaelin Jr. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing Biochem. Biophys. Res. Commun. 338 2005 627 638
10. E. Berra, E. Benizri, A. Ginouves, V. Volmat, D. Roux, and J. Pouyssegur HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia EMBO J. 22 2003 4082 4090
11. W.G. Kaelin Von Hippel-Lindau disease Annu. Rev. Pathol. 2 2007 145 173
12. P. Staller, J. Sulitkova, J. Lisztwan, H. Moch, E.J. Oakeley, and W. Krek Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL Nature 425 2003 307 311
13. D. Zagzag, B. Krishnamachary, H. Yee, H. Okuyama, L. Chiriboga, M.A. Ali, J. Melamed, and G.L. Semenza Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor Cancer Res. 65 2005 6178 6188
14. Hsu, T. (2012) Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: insights from model organisms. Oncogene, in press.
15. I.J. Frew, and W. Krek Multitasking by pVHL in tumour suppression Curr. Opin. Cell. Biol. 19 2007 685 690
16. R.S. Bindra, J.R. Vasselli, R. Stearman, W.M. Linehan, and R.D. Klausner VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells Cancer Res. 62 2002 3014 3019
17. P.E. Clark The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy Kidney Int. 76 2009 939 945
18. S. Wilhelm, C. Carter, M. Lynch, T. Lowinger, J. Dumas, R.A. Smith, B. Schwartz, R. Simantov, and S. Kelley Discovery and development of sorafenib: a multikinase inhibitor for treating cancer Nat. Rev. Drug Discovery 5 2006 835 844
19. V. Dammai, B. Adryan, K.R. Lavenburg, and T. Hsu Drosophila awd, the homolog of human nm23, regulates FGF receptor levels and functions synergistically with shi/dynamin during tracheal development Genes Dev. 17 2003 2812 2824
20. K.J. Champion, M. Guinea, V. Dammai, and T. Hsu Endothelial function of von Hippel-Lindau tumor suppressor gene: control of fibroblast growth factor receptor signaling Cancer Res. 68 2008 4649 4657
21. M.S. Lutz, and R.D. Burk Primary cilium formation requires von hippel-lindau gene function in renal-derived cells Cancer Res. 66 2006 6903 6907
22. B. Schermer, C. Ghenoiu, M. Bartram, R.U. Muller, F. Kotsis, M. Hohne, W. Kuhn, M. Rapka, R. Nitschke, H. Zentgraf, M. Fliegauf, H. Omran, G. Walz, and T. Benzing The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth J. Cell Biol. 175 2006 547 554
23. M.A. Esteban, S.K. Harten, M.G. Tran, and P.H. Maxwell Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein J. Am. Soc. Nephrol. 17 2006 1801 1806
24. J.S. Roe, H. Kim, S.M. Lee, S.T. Kim, E.J. Cho, and H.D. Youn P53 stabilization and transactivation by a von Hippel-Lindau protein Mol. Cell. 22 2006 395 405
25. S.R. Walmsley, N.N. McGovern, M.K. Whyte, and E.R. Chilvers The HIF/VHL pathway: from oxygen sensing to innate immunity Am. J. Respir. Cell Mol. Biol. 38 2008 251 255
26. H.Z. Imtiyaz, and M.C. Simon Hypoxia-inducible factors as essential regulators of inflammation Curr. Top. Microbiol. Immunol. 345 2010 105 120
27. V. Nizet, and R.S. Johnson Interdependence of hypoxic and innate immune responses Nat. Rev. Immunol. 9 2009 609 617
28. D.P. Gale, and P.H. Maxwell The role of HIF in immunity Int. J. Biochem. Cell. Biol. 42 2010 486 494
29. K. Takubo, N. Goda, W. Yamada, H. Iriuchishima, E. Ikeda, Y. Kubota, H. Shima, R.S. Johnson, A. Hirao, M. Suematsu, and T. Suda Regulation of the HIF-1alpha level is essential for hematopoietic stem cells Cell Stem Cell 7 2010 391 402
30. S.R. Walmsley, A.S. Cowburn, M.R. Clatworthy, N.W. Morrell, E.C. Roper, V. Singleton, P. Maxwell, M.K. Whyte, and E.R. Chilvers Neutrophils from patients with heterozygous germline mutations in the von Hippel Lindau protein (pVHL) display delayed apoptosis and enhanced bacterial phagocytosis Blood 108 2006 3176 3178
31. A. Hsouna, G. Nallamothu, N. Kose, M. Guinea, V. Dammai, and T. Hsu Drosophila von Hippel-Lindau tumor suppressor gene function in epithelial tubule morphogenesis Mol. Cell Biol. 30 2010 3779 3794
32. S.O. Ang, H. Chen, V.R. Gordeuk, A.I. Sergueeva, L.A. Polyakova, G.Y. Miasnikova, R. Kralovics, D.W. Stockton, and J.T. Prchal Endemic polycythemia in Russia: mutation in the VHL gene Blood Cells Mol. Dis. 28 2002 57 62
33. M.M. Hickey, J.C. Lam, N.A. Bezman, W.K. Rathmell, and M.C. Simon Von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2 alpha signaling and splenic erythropoiesis J. Clin. Invest. 117 2007 3879 3889
34. E. van Rooijen, E.E. Voest, I. Logister, J. Korving, T. Schwerte, S. Schulte-Merker, R.H. Giles, and F.J. van Eeden Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemia Blood 113 2009 6449 6460
35. R.C. Russell, R.I. Sufan, B. Zhou, P. Heir, S. Bunda, S.S. Sybingco, S.N. Greer, O. Roche, S.A. Heathcote, V.W. Chow, L.M. Boba, T.D. Richmond, M.M. Hickey, D.L. Barber, D.A. Cheresh, M.C. Simon, M.S. Irwin, W.Y. Kim, and M. Ohh Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia Nat. Med. 17 2011 845 853
36. W. Jelkmann Regulation of erythropoietin production J. Physiol-London 589 2011 1251 1258
37. P.H. Maxwell, M.K. Osmond, C.W. Pugh, A. Heryet, L.G. Nicholls, C.C. Tan, B.G. Doe, D.J. Ferguson, M.H. Johnson, and P.J. Ratcliffe Identification of the renal erythropoietin-producing cells using transgenic mice Kidney Int. 44 1993 1149 1162
38. S. Bachmann, M. Le Hir, and K.U. Eckardt Co-localization of erythropoietin mRNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin J. Histochem. Cytochem. 41 1993 335 341
39. P.H. Maxwell, D.J. Ferguson, M.K. Osmond, C.W. Pugh, A. Heryet, B.G. Doe, M.H. Johnson, and P.J. Ratcliffe Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells Blood 84 1994 1823 1830
40. K. Papworth, A. Bergh, K. Grankvist, B. Ljungberg, and T. Rasmuson Expression of erythropoietin and its receptor in human renal cell carcinoma Tumour Biol. 30 2009 86 92
41. M. Krieg, H.H. Marti, and K.H. Plate Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function Blood 92 1998 3388 3393
42. Y.S. Lee, A.O. Vortmeyer, I.A. Lubensky, T.W. Vogel, B. Ikejiri, S. Ferlicot, G. Benoit, S. Giraud, E.H. Oldfield, W.M. Linehan, B.T. Teh, S. Richard, and Z. Zhuang Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma Clin. Cancer Res. 11 2005 1059 1064
43. K. Gong, N. Zhang, Z. Zhang, and Y.Q. Na Coexpression of erythopoietin and erythopoietin receptor in sporadic clear cell renal cell carcinoma Cancer Biol. Ther. 5 2006 582 585
44. K. Shuai, and B. Liu Regulation of JAK-STAT signalling in the immune system Nat. Rev. Immunol. 3 2003 900 911
45. V.R. Gordeuk, A.I. Sergueeva, G.Y. Miasnikova, D. Okhotin, Y. Voloshin, P.L. Choyke, J.A. Butman, K. Jedlickova, J.T. Prchal, and L.A. Polyakova Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors Blood 103 2004 3924 3932
46. T.R. Lappin, A.P. Maxwell, and P.G. Johnston EPO's alter ego: erythropoietin has multiple actions Stem Cells 20 2002 485 492
47. M.O. Arcasoy The non-haematopoietic biological effects of erythropoietin Br. J. Haematol. 141 2008 14 31
48. S. Purhonen, J. Palm, D. Rossi, N. Kaskenpaa, I. Rajantie, S. Yla-Herttuala, K. Alitalo, I.L. Weissman, and P. Salven Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth Proc. Natl. Acad. Sci U S A 105 2008 6620 6625
49. C.C. Hand, and M. Brines Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward? J. Investig. Med. 59 2011 1073 1082
50. B. Leyland-Jones, and J.A. O'Shaughnessy Erythropoietin as a critical component of breast cancer therapy: survival, synergistic, and cognitive applications Semin. Oncol. 30 2003 174 184
51. M. Henke, R. Laszig, C. Rube, U. Schafer, K.D. Haase, B. Schilcher, S. Mose, K.T. Beer, U. Burger, C. Dougherty, and H. Frommhold Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial Lancet 362 2003 1255 1260
52. M.O. Arcasoy, X. Jiang, and Z.A. Haroon Expression of erythropoietin receptor splice variants in human cancer Biochem. Biophys. Res. Commun. 307 2003 999 1007
53. Y. Yasuda, Y. Fujita, S. Masuda, T. Musha, K. Ueda, H. Tanaka, H. Fujita, T. Matsuo, M. Nagao, R. Sasaki, and Y. Nakamura Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs Carcinogenesis 23 2002 1797 1805
54. G. Acs, P.J. Zhang, C.M. McGrath, P. Acs, J. McBroom, A. Mohyeldin, S. Liu, H. Lu, and A. Verma Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression Am. J. Pathol. 162 2003 1789 1806
55. S. Batra, N. Perelman, L.R. Luck, H. Shimada, and P. Malik Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival Lab. Invest. 83 2003 1477 1487
56. Y. Yasuda, Y. Fujita, T. Matsuo, S. Koinuma, S. Hara, A. Tazaki, M. Onozaki, M. Hashimoto, T. Musha, K. Ogawa, H. Fujita, Y. Nakamura, H. Shiozaki, and H. Utsumi Erythropoietin regulates tumour growth of human malignancies Carcinogenesis 24 2003 1021 1029
57. C. Peyssonnaux, A.S. Zinkernagel, R.A. Schuepbach, E. Rankin, S. Vaulont, V.H. Haase, V. Nizet, and R.S. Johnson Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs) J. Clin. Invest. 117 2007 1926 1932
58. K. Gong, N. Zhang, K. Zhang, and Y. Na The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1alpha and -2alpha in sporadic clear cell renal carcinoma Int. J. Mol. Med. 26 2010 907 912
59. M.C. Bento, K.T. Chang, Y. Guan, E. Liu, G. Caldas, R.A. Gatti, and J.T. Prchal Congenital polycythemia with homozygous and heterozygous mutations of von Hippel-Lindau gene: five new Caucasian patients Haematologica 90 2005 128 129
60. H. Cario, K. Schwarz, N. Jorch, U. Kyank, P.E. Petrides, D.T. Schneider, R. Uhle, K.M. Debatin, and E. Kohne Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis Haematologica 90 2005 19 24
61. Y.D. Pastore, J. Jelinek, S. Ang, Y. Guan, E. Liu, K. Jedlickova, L. Krishnamurti, and J.T. Prchal Mutations in the VHL gene in sporadic apparently congenital polycythemia Blood 101 2003 1591 1595
62. T.A. Waldmann, E.H. Levin, and M. Baldwin The association of polycythemia with a cerebellar hemangioblastoma. The production of an erythropoiesis stimulating factor by the tumor Am. J. Med. 31 1961 318 324
63. S.M. Watt, A. Athanassopoulos, A.L. Harris, and G. Tsaknakis Human endothelial stem/progenitor cells, angiogenic factors and vascular repair J R Soc. Interface 7 Suppl. 6 2010 S731 S751
64. M.R. Richardson, and M.C. Yoder Endothelial progenitor cells: quo vadis? J. Mol. Cell Cardiol. 50 2011 266 272
65. B.Z. Qian, and J.W. Pollard Macrophage diversity enhances tumor progression and metastasis Cell 141 2010 39 51
66. D. Gao, D.J. Nolan, A.S. Mellick, K. Bambino, K. McDonnell, and V. Mittal Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis Science 319 2008 195 198
67. R.S. Bhatt, A.J. Zurita, A. O'Neill, A. Norden-Zfoni, L. Zhang, H.K. Wu, P.Y. Wen, D. George, V.P. Sukhatme, M.B. Atkins, and J.V. Heymach Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma Br. J. Cancer 105 2011 112 117
68. F. Farace, M. Gross-Goupil, E. Tournay, M. Taylor, N. Vimond, N. Jacques, F. Billiot, A. Mauguen, C. Hill, and B. Escudier Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors Br. J. Cancer 104 2011 1144 1150
69. F.H. Rad, A. Ulusakarya, S. Gad, M. Sibony, F. Juin, S. Richard, D. Machover, and G. Uzan Novel somatic mutations of the VHL gene in an erythropoietin-producing renal carcinoma associated with secondary polycythemia and elevated circulating endothelial progenitor cells Am. J. Hematol. 83 2008 155 158
70. C. Heeschen, A. Aicher, R. Lehmann, S. Fichtlscherer, M. Vasa, C. Urbich, C. Mildner-Rihm, H. Martin, A.M. Zeiher, and S. Dimmeler Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization Blood 102 2003 1340 1346
71. S. Kusmartsev, E. Eruslanov, H. Kubler, T. Tseng, Y. Sakai, Z. Su, S. Kaliberov, A. Heiser, C. Rosser, P. Dahm, D. Siemann, and J. Vieweg Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma J. Immunol. 181 2008 346 353
72. H.Z. Imtiyaz, E.P. Williams, M.M. Hickey, S.A. Patel, A.C. Durham, L.J. Yuan, R. Hammond, P.A. Gimotty, B. Keith, and M.C. Simon Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation J. Clin. Invest. 120 2010 2699 2714
73. H. Kojima, A. Kobayashi, D. Sakurai, Y. Kanno, H. Hase, R. Takahashi, Y. Totsuka, G.L. Semenza, M.V. Sitkovsky, and T. Kobata Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine B cell development in bone marrow J. Immunol. 184 2010 154 163
74. T. Cramer, Y. Yamanishi, B.E. Clausen, I. Forster, R. Pawlinski, N. Mackman, V.H. Haase, R. Jaenisch, M. Corr, V. Nizet, G.S. Firestein, H.P. Gerber, N. Ferrara, and R.S. Johnson HIF-1alpha is essential for myeloid cell-mediated inflammation Cell 112 2003 645 657
75. T. Simsek, F. Kocabas, J. Zheng, R.J. Deberardinis, A.I. Mahmoud, E.N. Olson, J.W. Schneider, C.C. Zhang, and H.A. Sadek The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche Cell Stem Cell 7 2010 380 390
76. H. Kojima, H. Gu, S. Nomura, C.C. Caldwell, T. Kobata, P. Carmeliet, G.L. Semenza, and M.V. Sitkovsky Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha -deficient chimeric mice Proc. Natl. Acad. Sci. U S A 99 2002 2170 2174
77. K. Amara, M. Trimeche, S. Ziadi, A. Laatiri, M. Hachana, and S. Korbi Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas Ann. Oncol. 19 2008 1774 1786
78. M. Kanduri, N. Cahill, H. Goransson, C. Enstrom, F. Ryan, A. Isaksson, and R. Rosenquist Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia Blood 115 2010 296 305
79. A.K. Ghosh, T.D. Shanafelt, A. Cimmino, C. Taccioli, S. Volinia, C.G. Liu, G.A. Calin, C.M. Croce, D.A. Chan, A.J. Giaccia, C. Secreto, L.E. Wellik, Y.K. Lee, D. Mukhopadhyay, and N.E. Kay Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells Blood 113 2009 5568 5574
80. M. Kalac, L. Scotto, E. Marchi, J. Amengual, V.E. Seshan, G. Bhagat, N. Ulahannan, V.V. Leshchenko, A.M. Temkin, S. Parekh, B. Tycko, and O.A. O'Connor HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL Blood 118 2011 5506 5516
81. A.K. Neumann, J. Yang, M.P. Biju, S.K. Joseph, R.S. Johnson, V.H. Haase, B.D. Freedman, and L.A. Turka Hypoxia inducible factor 1 alpha regulates T cell receptor signal transduction Proc. Natl. Acad. Sci. U S A 102 2005 17071 17076
82. M.P. Biju, A.K. Neumann, S.J. Bensinger, R.S. Johnson, L.A. Turka, and V.H. Haase Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes Mol. Cell. Biol. 24 2004 9038 9047
83. D. Lukashev, B. Klebanov, H. Kojima, A. Grinberg, A. Ohta, L. Berenfeld, R.H. Wenger, and M. Sitkovsky Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes J. Immunol. 177 2006 4962 4965
84. M. Thiel, C.C. Caldwell, S. Kreth, S. Kuboki, P. Chen, P. Smith, A. Ohta, A.B. Lentsch, D. Lukashev, and M.V. Sitkovsky Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival PLoS One 2 2007 e853
85. Y. Makino, H. Nakamura, E. Ikeda, K. Ohnuma, K. Yamauchi, Y. Yabe, L. Poellinger, Y. Okada, C. Morimoto, and H. Tanaka Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells J. Immunol. 171 2003 6534 6540
86. E.V. Dang, J. Barbi, H.Y. Yang, D. Jinasena, H. Yu, Y. Zheng, Z. Bordman, J. Fu, Y. Kim, H.R. Yen, W. Luo, K. Zeller, L. Shimoda, S.L. Topalian, G.L. Semenza, C.V. Dang, D.M. Pardoll, and F. Pan Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1 Cell 146 2011 772 784
87. S.F. Ziegler, and J.H. Buckner FOXP3 and the regulation of Treg/Th17 differentiation Microbes Infect. 11 2009 594 598
88. C. Peyssonnaux, V. Datta, T. Cramer, A. Doedens, E.A. Theodorakis, R.L. Gallo, N. Hurtado-Ziola, V. Nizet, and R.S. Johnson HIF-1alpha expression regulates the bactericidal capacity of phagocytes J. Clin. Invest. 115 2005 1806 1815
89. N. Olson, and A. van der Vliet Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease Nitric Oxide 25 2011 125 137
90. M.M. Hickey, T. Richardson, T. Wang, M. Mosqueira, E. Arguiri, H. Yu, Q.C. Yu, C.C. Solomides, E.E. Morrisey, T.S. Khurana, M. Christofidou-Solomidou, and M.C. Simon The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice J. Clin. Invest. 120 2010 827 839
91. K.L. Talks, H. Turley, K.C. Gatter, P.H. Maxwell, C.W. Pugh, P.J. Ratcliffe, and A.L. Harris The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages Am. J. Pathol. 157 2000 411 421
92. K. Brukamp, B. Jim, M.J. Moeller, and V.H. Haase Hypoxia and podocyte-specific Vhlh deletion confer risk of glomerular disease Am. J. Physiol. Renal Physiol. 293 2007 F1397 F1407
93. K. Kimura, M. Iwano, D.F. Higgins, Y. Yamaguchi, K. Nakatani, K. Harada, A. Kubo, Y. Akai, E.B. Rankin, E.G. Neilson, V.H. Haase, and Y. Saito Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis Am. J. Physiol. Renal Physiol. 295 2008 F1023 F1029
94. D.F. Higgins, K. Kimura, W.M. Bernhardt, N. Shrimanker, Y. Akai, B. Hohenstein, Y. Saito, R.S. Johnson, M. Kretzler, C.D. Cohen, K.U. Eckardt, M. Iwano, and V.H. Haase Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition J. Clin. Invest. 117 2007 3810 3820
95. R.E. Schietke, T. Hackenbeck, M. Tran, R. Gunther, B. Klanke, C.L. Warnecke, K.X. Knaup, D. Shukla, C. Rosenberger, R. Koesters, S. Bachmann, P. Betz, G. Schley, J. Schodel, C. Willam, T. Winkler, K. Amann, K.U. Eckardt, P. Maxwell, and M.S. Wiesener Renal tubular HIF-2alpha expression requires VHL inactivation and causes fibrosis and cysts PLoS One 7 2012 e31034
96. S. Galban, J. Fan, J.L. Martindale, C. Cheadle, B. Hoffman, M.P. Woods, G. Temeles, J. Brieger, J. Decker, and M. Gorospe Von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays Mol. Cell. Biol. 23 2003 2316 2328
97. S. Ananth, B. Knebelmann, W. Gruning, M. Dhanabal, G. Walz, I.E. Stillman, and V.P. Sukhatme Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma Cancer Res. 59 1999 2210 2216
98. H. Yang, Y.A. Minamishima, Q. Yan, S. Schlisio, B.L. Ebert, X. Zhang, L. Zhang, W.Y. Kim, A.F. Olumi, and W.G. Kaelin Jr. PVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2 Mol. Cell. 28 2007 15 27
99. J. An, and M.B. Rettig Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity Mol. Cell. Biol. 25 2005 7546 7556
100. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 2009 1073 1081
101. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
102. S. Kraus, and N. Arber Inflammation and colorectal cancer Curr. Opin. Pharmacol. 9 2009 405 410
103. S.P. Hussain, L.J. Hofseth, and C.C. Harris Radical causes of cancer Nat. Rev. Cancer 3 2003 276 285
104. J.C. Koster, M.A. Permutt, and C.G. Nichols Diabetes and insulin secretion: the ATP-sensitive K+ channel (K ATP) connection Diabetes 54 2005 3065 3072
105. J. Cantley, C. Selman, D. Shukla, A.Y. Abramov, F. Forstreuter, M.A. Esteban, M. Claret, S.J. Lingard, M. Clements, S.K. Harten, H. Asare-Anane, R.L. Batterham, P.L. Herrera, S.J. Persaud, M.R. Duchen, P.H. Maxwell, and D.J. Withers Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice J. Clin. Invest. 119 2009 125 135
106. J. Zehetner, C. Danzer, S. Collins, K. Eckhardt, P.A. Gerber, P. Ballschmieter, J. Galvanovskis, K. Shimomura, F.M. Ashcroft, B. Thorens, P. Rorsman, and W. Krek PVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells Genes Dev. 22 2008 3135 3146
107. D. Choi, E.P. Cai, S.A. Schroer, L. Wang, and M. Woo Vhl is required for normal pancreatic beta cell function and the maintenance of beta cell mass with age in mice Lab. Invest. 91 2011 527 538
108. S. Puri, D.A. Cano, and M. Hebrok A role for von Hippel-Lindau protein in pancreatic beta-cell function Diabetes 58 2009 433 441
109. H.C. Shen, A. Adem, K. Ylaya, A. Wilson, M. He, D. Lorang, S.M. Hewitt, K. Pechhold, D.M. Harlan, I.A. Lubensky, L.S. Schmidt, W.M. Linehan, and S.K. Libutti Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations PLoS One 4 2009 e4897
110. J. Cantley, S.T. Grey, P.H. Maxwell, and D.J. Withers The hypoxia response pathway and beta-cell function Diabetes Obes. Metab. 12 Suppl 2 2010 159 167
111. X. Liang, D. Shen, Y. Huang, C. Yin, C.M. Bojanowski, Z. Zhuang, and C.C. Chan Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease Ophthalmology 114 2007 147 156
112. J.A. Butman, W.M. Linehan, and R.R. Lonser Neurologic manifestations of von Hippel-Lindau disease JAMA 300 2008 1334 1342
113. R.R. Lonser, A.O. Vortmeyer, J.A. Butman, S. Glasker, M.A. Finn, J.M. Ammerman, M.J. Merrill, N.A. Edwards, Z. Zhuang, and E.H. Oldfield Edema is a precursor to central nervous system peritumoral cyst formation Ann. Neurol. 58 2005 392 399
114. S. Glasker, A.O. Vortmeyer, R.R. Lonser, I.A. Lubensky, H. Okamoto, J.B. Xia, J. Li, E. Milne, J.A. Kowalak, E.H. Oldfield, and Z. Zhuang Proteomic analysis of hemangioblastoma cyst fluid Cancer Biol. Ther. 5 2006 549 553
115. J.Y. Lee, S.M. Dong, W.S. Park, N.J. Yoo, C.S. Kim, J.J. Jang, J.G. Chi, B. Zbar, I.A. Lubensky, W.M. Linehan, A.O. Vortmeyer, and Z. Zhuang Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas Cancer Res. 58 1998 504 508
116. A.O. Vortmeyer, J.R. Gnarra, M.R. Emmert-Buck, D. Katz, W.M. Linehan, E.H. Oldfield, and Z. Zhuang Von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease Hum. Pathol. 28 1997 540 543
117. A.O. Vortmeyer, S.C. Huang, S.D. Pack, C.A. Koch, I.A. Lubensky, E.H. Oldfield, and Z. Zhuang Somatic point mutation of the wild-type allele detected in tumors of patients with VHL germline deletion Oncogene 21 2002 1167 1170
118. S. Wizigmann-Voos, G. Breier, W. Risau, and K.H. Plate Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas Cancer Res. 55 1995 1358 1364
119. S. Glasker, J. Li, J.B. Xia, H. Okamoto, W. Zeng, R.R. Lonser, Z. Zhuang, E.H. Oldfield, and A.O. Vortmeyer Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell Cancer Res. 66 2006 4167 4172
120. A.O. Vortmeyer, S. Frank, S.Y. Jeong, K. Yuan, B. Ikejiri, Y.S. Lee, D. Bhowmick, R.R. Lonser, R. Smith, G. Rodgers, E.H. Oldfield, and Z. Zhuang Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease Cancer Res. 63 2003 7051 7055
121. D.M. Park, Z. Zhuang, L. Chen, N. Szerlip, I. Maric, J. Li, T. Sohn, S.H. Kim, I.A. Lubensky, A.O. Vortmeyer, G.P. Rodgers, E.H. Oldfield, and R.R. Lonser Von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells PLoS Med. 4 2007 e60
122. S.B. Shively, S. Beltaifa, B. Gehrs, H. Duong, J. Smith, N.A. Edwards, R. Lonser, M. Raffeld, and A.O. Vortmeyer Protracted haemangioblastic proliferation and differentiation in von Hippel-Lindau disease J. Pathol. 216 2008 514 520
123. J. Palis, J. Malik, K.E. McGrath, and P.D. Kingsley Primitive erythropoiesis in the mammalian embryo Int. J. Dev. Biol. 54 2010 1011 1018
124. C. Lancrin, P. Sroczynska, C. Stephenson, T. Allen, V. Kouskoff, and G. Lacaud The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage Nature 457 2009 892 895
125. H.M. Eilken, S. Nishikawa, and T. Schroeder Continuous single-cell imaging of blood generation from haemogenic endothelium Nature 457 2009 896 900
126. J.A. Feldenzer, and P.E. McKeever Selective localization of gamma-enolase in stromal cells of cerebellar hemangioblastomas Acta Neuropathol. 72 1987 281 285
127. J.W. Grant, P.J. Gallagher, and C. Hedinger Haemangioblastoma. An immunohistochemical study of ten cases Acta Neuropathol. 76 1988 82 86
128. A. Omulecka, B. Lach, J. Alwasiak, and A. Gregor Immunohistochemical and ultrastructural studies of stromal cells in hemangioblastoma Folia Neuropathol. 33 1995 41 50
129. K. Ishizawa, T. Komori, and T. Hirose Stromal cells in hemangioblastoma: neuroectodermal differentiation and morphological similarities to ependymoma Pathol. Int. 55 2005 377 385
130. A.D. Polydorides, M.K. Rosenblum, and M.A. Edgar Metastatic renal cell carcinoma to hemangioblastoma in von Hippel-Lindau disease Arch. Pathol. Lab. Med. 131 2007 641 645
131. T. Bohling, A. Maenpaa, T. Timonen, L. Vantunen, A. Paetau, and M. Haltia Different expression of adhesion molecules on stromal cells and endothelial cells of capillary hemangioblastoma Acta Neuropathol. 92 1996 461 466
132. J.J. Kepes, S.S. Rengachary, and S.H. Lee Astrocytes in hemangioblastomas of the central nervous system and their relationship to stromal cells Acta Neuropathol. 47 1979 99 104
133. M. Hasselblatt, A. Jeibmann, J. Gerss, C. Behrens, B. Rama, H. Wassmann, and W. Paulus Cellular and reticular variants of haemangioblastoma revisited: a clinicopathologic study of 88 cases Neuropathol. Appl. Neurobiol. 31 2005 618 622
134. S.B. Shively, E.A. Falke, J. Li, M.G. Tran, E.R. Thompson, P.H. Maxwell, E. Roessler, E.H. Oldfield, R.R. Lonser, and A.O. Vortmeyer Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease Mod. Pathol. 24 2011 1023 1030
135. A.O. Vortmeyer, Q. Yuan, Y.S. Lee, Z. Zhuang, and E.H. Oldfield Developmental effects of von Hippel-Lindau gene deficiency Ann. Neurol. 55 2004 721 728
136. A.O. Vortmeyer, M.G. Tran, W. Zeng, S. Glasker, C. Riley, M. Tsokos, B. Ikejiri, M.J. Merrill, M. Raffeld, Z. Zhuang, R.R. Lonser, P.H. Maxwell, and E.H. Oldfield Evolution of VHL tumourigenesis in nerve root tissue J. Pathol. 210 2006 374 382
137. I. Kato, A. Niwa, T. Heike, H. Fujino, M.K. Saito, K. Umeda, H. Hiramatsu, M. Ito, M. Morita, Y. Nishinaka, S. Adachi, F. Ishikawa, and T. Nakahata Identification of hepatic niche harboring human acute lymphoblastic leukemic cells via the SDF-1/CXCR4 axis PLoS One 6 2011 e27042
138. M.C. Tiveron, and H. Cremer CXCL12/CXCR4 signalling in neuronal cell migration Curr. Opin. Neurobiol. 18 2008 237 244